TRENTON, N.J. — A generic drug maker plans to start selling a slightly cheaper version of the EpiPen in the U.S. early next year.

Drug maker Sandoz said Thursday the price of two generic injectors will be $250 without insurance. Two other generics on the market in the U.S. cost $300 a pair. Brand-name EpiPens sold by Mylan cost at least twice as much.

The price people pay varies, though, depending on insurance and discounts.

The pen like injectors are used to treat life-threatening allergic reactions. Brand-name EpiPen, which dominates the market, has been in short supply since spring because of production problems.

Mylan was blasted in the past for price hikes that pushed the price over $600. It responded by selling its own generic.